NBS superfood: a promising adjunctive therapy in critically ill ICU patients with omicron variant of COVID-19

AMB Express

Table 1 Summary of the clinical characteristics and laboratory results of all patients in both the intervention and control groups at both the baseline and the 14-day post-intervention

Variables (unit)	Control group (baseline) N = 200			Control group (after intervention) N = 200			P-value
Variables (unit)	Mean	Std. deviation	Std. error mean	Mean	Std. deviation	Std. error mean	P-value
CRP (mg/L)	37.6350	24.17548	1.70946	48.4850	32.60113	2.30525	0.000^a
ESR (mm/h)	28.0000	16.52408	1.16843	34.0350	16.07938	1.13698	0.000^a
D-Dimer (ng/ml)	759.2600	503.91503	35.63217	1009.1300	699.12253	49.43543	0.000^a
CPK (U/L)	97.4550	81.17719	5.74009	131.4800	102.95103	7.27974	0.000^a
Lymphocyte count	1206.3800	374.83656	26.50495	1152.5950	551.33028	38.98494	0.035^a

Variables (unit)	Intervention group (baseline) N = 200			Intervention group (after intervention) N = 200			P-value
Variables (unit)	Mean	Std. deviation	Std. error mean	Mean	Std. deviation	Std. error mean	P-value
CRP (mg/L)	40.7950	27.96575	1.97748	15.3850	11.54745	0.81653	0.000^a
ESR (mm/h)	26.4550	15.29732	1.08168	14.2750	8.09674	0.57253	0.000^a
D-Dimer (ng/ml)	807.7950	438.69631	31.02051	485.1750	279.05622	19.73225	0.000^a
CPK (U/L)	100.1150	84.44416	5.97110	68.9300	57.35804	4.05583	0.000^a
Lymphocyte count	1135.5350	362.60799	25.64026	1537.0600	469.04103	33.16621	0.000^a

C-Reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR), D-Dimer (a fibrin degradation product), Creatine Phosphokinase (CPK), N: number of samples
^aPaired t-test